What this trial studies
This study aimed to evaluate the effect of carbohydrate quality on quality of life and menopausal symptoms in postmenopausal women. Data were collected from 604 postmenopausal women using a demographic questionnaire, the Menopause-Specific Quality of Life Questionnaire (MENQOL), and the Menopause Rating Scale (MRS). Carbohydrate quality was assessed using food frequency consumption data, and the results were analyzed with SPSS 24 software.
Conditions in scope
- Woman
Interventions
- Not specified in the public record.
Who can join
Women only · Ages 30 Years to 90 Years · Accepts healthy volunteers.
Inclusion criteria
- Women who have not menstruated for 12 consecutive months and have no intermenstrual bleeding
- Aged between 30 and 90 years
- Must be willing to volunteer
Exclusion criteria
- Women diagnosed with any psychological disorder
- Cancer patients
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Ankara | Ankara Yıldırım Beyazıt University | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Observational
- Phase: N/A
- Start date: 2023-01-01
- Primary completion: 2023-06-15
- Last update posted: 2024-10-30
- First posted: 2024-10-30
Sponsor & contact
Lead sponsor: Ankara Yildirim Beyazıt University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Evaluating carbohydrate quality (Basaline)
132 food groups obtained from the food consumption frequency questionnaire were analyzed. Daily intake (g/day) was calculated using the BeBiS program with a global database, based on the amount and frequency of food consumed by participants. Glycaemic Index (GI) values were also determined using the BeBiS program, taking into account both the amount and frequency of food consumed. To determine…
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06666244 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.